Cristin Hubbard

EVP, Chief Commercial Officer, BioMarin Pharmaceutical.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 20, 2026Shares withheld for tax 2,318 shares at $50.20 of BioMarin Pharmaceutical²
Mar 17, 2026Shares withheld for tax 1,245 shares at $56.05 of BioMarin Pharmaceutical³
Mar 16, 2026Granted 15,410 shares of BioMarin Pharmaceutical³
Oct 31, 2025Granted 80 shares at $45.54 of BioMarin Pharmaceutical⁴
May 20, 2025Shares withheld for tax 2,155 shares at $59.93 of BioMarin Pharmaceutical⁵
May 2, 2025Sold 273 shares at $64.92 of BioMarin Pharmaceutical⁶
Apr 30, 2025Granted 273 shares at $54.14 of BioMarin Pharmaceutical⁶
Mar 17, 2025Granted 13,310 shares of BioMarin Pharmaceutical⁷
May 20, 2024Granted 4,700 shares of BioMarin Pharmaceutical⁸
May 20, 2024Granted 14,690 shares of BioMarin Pharmaceutical⁸

The numbers on this page point here. Each one links to the record it came from.